Profilin 2 (PFN2) promotes the proliferation, migration, invasion and epithelial-to-mesenchymal transition of triple negative breast cancer cells

被引:0
作者
Yuwei Ling
Qi Cao
Yihan Liu
Jing Zhao
Ye Zhao
Kaifu Li
Zhiqiang Chen
Xiaoyan Du
Xueyun Huo
Hua Kang
Zhenwen Chen
机构
[1] Capital Medical University,Department of General Surgery, Center for Thyroid and Breast Surgery, Xuanwu Hospital
[2] Capital Medical University,School of Basic Medical Sciences, Beijing Key Laboratory of Cancer Invasion and Metastasis Research
来源
Breast Cancer | 2021年 / 28卷
关键词
Triple negative breast cancer; PFN2; Epithelial-to-mesenchymal transition;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:368 / 378
页数:10
相关论文
共 54 条
[1]  
Foulkes WD(2010)Triple-negative breast cancer N Engl J Med 363 1938-1948
[2]  
Smith IE(2017)Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer Breast Cancer Res Treat 161 279-287
[3]  
Reis-Filho JS(2016)A review of systemic treatment in metastatic triple-negative breast cancer Breast Cancer (Auckl) 10 25-36
[4]  
Li X(2008)The profilin:actin complex localizes to sites of dynamic actin polymerization at the leading edge of migrating cells and pathogen-induced actin tails Eur J Cell Biol 87 893-904
[5]  
Yang J(2017)MicroRNA-30a-5p suppresses epithelial-mesenchymal transition by targeting profilin-2 in high invasive non-small cell lung cancer cell lines Oncol Rep 37 3146-3154
[6]  
Peng L(2015)Epigenetic regulation of Smad2 and Smad3 by profilin-2 promotes lung cancer growth and metastasis Nat Commun 6 8230-1128
[7]  
Zeichner SB(2018)Loss of profilin 2 contributes to enhanced epithelial-mesenchymal transition and metastasis of colorectal cancer Int J Oncol 53 1118-1446
[8]  
Terawaki H(2015)Profilin 2 promotes migration, invasion, and stemness of HT29 human colorectal cancer stem cells Biosci Biotechnol Biochem 79 1438-823
[9]  
Gogineni K(2011)Decreased expression of profilin 2 in oral squamous cell carcinoma and its clinicopathological implications Oncol Rep 26 813-459
[10]  
Li Y(2016)PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma J Transl Med 14 137-1088